Phase 1 Breast Adenocarcinoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+97 more

Mayo Clinic132 enrolled1 locationNCT05269381

Recruiting

Phase 1Phase 2

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Endometrial CancerPrimary Peritoneal CarcinomaNon-small Cell Lung Cancer+6 more

Genmab764 enrolled67 locationsNCT05579366

Recruiting

Phase 1Phase 2

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Breast Adenocarcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University96 enrolled1 locationNCT06596018